Brief: AB Science Consolidated Net Loss AT EUR 13,615K
April 28 (Reuters) - Ab Science Sa ABS.PA :
* AB SCIENCE REPORTS ITS REVENUES FOR THE YEAR 2022 AND
PROVIDES
AN UPDATE ON ITS ACTIVITIES
* CONSOLIDATED OPERATING LOSS OF EUR 15.9 MILLION AS OF 31
DECEMBER 2022, COMPARED WITH A LOSS OF EUR 13.8 MILLION AS OF 31
DECEMBER 2021
* CONSOLIDATED NET LOSS AT 31 DECEMBER 2022 IS EUR 13,615K
COMPARED TO A LOSS OF EUR 14,463K AS OF 31 DECEMBER 2021, A
DECREASE OF 5.9%.
* 2022 NET TURNOVER EUR 2022 NET TURNOVER EUR 958 THOUSAND
Source text for Eikon: ID:
Further company coverage: ABS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com))
Recent news on AB Science SA
See all newsBrief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041
Brief: AB Science Phase 1 AML Study Of AB8939 Shows 100% Partial Response Rate
Brief: AB Science Receives Notice Of Allowance For European Patent Covering Masitinib Until 2040 In Treatment Of Sickle Cell Disease